FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016805863> ?p ?o ?g. }

• W2016805863 endingPage "349" @default.
• W2016805863 startingPage "342" @default.
• W2016805863 abstract "Chronic hyperplastic eosinophilic sinusitis (CHS) results from the unregulated proliferation of eosinophils, T(H)2-like lymphocytes, goblet cells, mast cells, and fibroblasts and is present in most patients with asthma. The frequent coexpression of these disorders and their shared pathophysiology suggests that these are similar disorders affecting the upper and lower airways.We evaluated the expression of cysteinyl leukotrienes (CysLTs) in sinus tissue from subjects with CHS compared with that seen in healthy sinus tissue.Nasal polyp and sinus tissue was evaluated from 58 individuals undergoing elective functional endoscopic sinus surgery. The diagnosis of CHS was demonstrated through the presence of eosinophilia and activated (EG2(+)) eosinophils, as determined by means of tissue immunohistochemistry. Data were compared with those from both nasal polyp tissue without eosinophilic inflammation and healthy control sinus tissue obtained from the sinus ostiomeatal complex at the time of surgery for unrelated disorders. CysLTs were quantified by means of ELISA in lipid-extracted tissue. Activation of the metabolic pathway leading to CysLT synthesis was demonstrated by ribonuclease protection. Subjects were genotyped for leukotriene C(4) (LTC(4)) synthase C-to-A promoter polymorphism.CysLT concentrations were significantly higher in tissue obtained from subjects with CHS (776.7 +/- 201.9 pg/g tissue) compared with that seen in healthy sinus tissue (355.7 +/- 101.6 pg/g tissue, P <.03). CysLT concentrations within noneosinophilic nasal polyps (328.0 +/- 116.4 pg/g tissue) were similar to those in control tissue. The presence of CysLTs in CHS was associated with increased expression of LTC(4) synthase mRNA. The C-to-A promoter polymorphism was associated with trends toward the increased presence of CHS and CysLTs.CHS is characterized by the increased presence of CysLTs when compared with concentrations seen in tissue from patients with chronic inflammatory sinusitis or healthy sinus tissue. These studies support the use of LT modifiers as anti-inflammatory agents that might have clinical benefit in patients with these disorders." @default.
• W2016805863 created "2016-06-24" @default.
• W2016805863 creator A5008942739 @default.
• W2016805863 creator A5015417510 @default.
• W2016805863 creator A5038840361 @default.
• W2016805863 creator A5048872172 @default.
• W2016805863 creator A5050381621 @default.
• W2016805863 creator A5063948687 @default.
• W2016805863 creator A5079959172 @default.
• W2016805863 creator A5087914830 @default.
• W2016805863 date "2003-02-01" @default.
• W2016805863 modified "2023-10-16" @default.
• W2016805863 title "Cysteinyl leukotriene expression in chronic hyperplastic sinusitis–nasal polyposis: Importance to eosinophilia and asthma" @default.
• W2016805863 cites W1574785846 @default.
• W2016805863 cites W1900718892 @default.
• W2016805863 cites W1966013656 @default.
• W2016805863 cites W1967224057 @default.
• W2016805863 cites W1971569966 @default.
• W2016805863 cites W1972372023 @default.
• W2016805863 cites W1974033149 @default.
• W2016805863 cites W1994505336 @default.
• W2016805863 cites W1994542428 @default.
• W2016805863 cites W2025319081 @default.
• W2016805863 cites W2025712618 @default.
• W2016805863 cites W2027242741 @default.
• W2016805863 cites W2030916726 @default.
• W2016805863 cites W2034205029 @default.
• W2016805863 cites W2035866307 @default.
• W2016805863 cites W2040836319 @default.
• W2016805863 cites W2042324713 @default.
• W2016805863 cites W2049700875 @default.
• W2016805863 cites W2050666825 @default.
• W2016805863 cites W2054855935 @default.
• W2016805863 cites W2060339350 @default.
• W2016805863 cites W2084775137 @default.
• W2016805863 cites W2091722094 @default.
• W2016805863 cites W2098289285 @default.
• W2016805863 cites W2111704171 @default.
• W2016805863 cites W2126577206 @default.
• W2016805863 cites W2136073528 @default.
• W2016805863 cites W2140744577 @default.
• W2016805863 cites W2148493195 @default.
• W2016805863 cites W2151732433 @default.
• W2016805863 cites W2157681529 @default.
• W2016805863 cites W2159534559 @default.
• W2016805863 cites W2166267022 @default.
• W2016805863 cites W2314937352 @default.
• W2016805863 cites W25517063 @default.
• W2016805863 cites W4233854517 @default.
• W2016805863 cites W4240055119 @default.
• W2016805863 cites W4246005998 @default.
• W2016805863 doi "https://doi.org/10.1067/mai.2003.67" @default.
• W2016805863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12589355" @default.
• W2016805863 hasPublicationYear "2003" @default.
• W2016805863 type Work @default.
• W2016805863 sameAs 2016805863 @default.
• W2016805863 citedByCount "133" @default.
• W2016805863 countsByYear W20168058632012 @default.
• W2016805863 countsByYear W20168058632013 @default.
• W2016805863 countsByYear W20168058632014 @default.
• W2016805863 countsByYear W20168058632015 @default.
• W2016805863 countsByYear W20168058632016 @default.
• W2016805863 countsByYear W20168058632017 @default.
• W2016805863 countsByYear W20168058632018 @default.
• W2016805863 countsByYear W20168058632019 @default.
• W2016805863 countsByYear W20168058632020 @default.
• W2016805863 countsByYear W20168058632021 @default.
• W2016805863 countsByYear W20168058632022 @default.
• W2016805863 countsByYear W20168058632023 @default.
• W2016805863 crossrefType "journal-article" @default.
• W2016805863 hasAuthorship W2016805863A5008942739 @default.
• W2016805863 hasAuthorship W2016805863A5015417510 @default.
• W2016805863 hasAuthorship W2016805863A5038840361 @default.
• W2016805863 hasAuthorship W2016805863A5048872172 @default.
• W2016805863 hasAuthorship W2016805863A5050381621 @default.
• W2016805863 hasAuthorship W2016805863A5063948687 @default.
• W2016805863 hasAuthorship W2016805863A5079959172 @default.
• W2016805863 hasAuthorship W2016805863A5087914830 @default.
• W2016805863 hasBestOaLocation W20168058631 @default.
• W2016805863 hasConcept C10162356 @default.
• W2016805863 hasConcept C142724271 @default.
• W2016805863 hasConcept C203014093 @default.
• W2016805863 hasConcept C2776042228 @default.
• W2016805863 hasConcept C2776914184 @default.
• W2016805863 hasConcept C2777129736 @default.
• W2016805863 hasConcept C2777768476 @default.
• W2016805863 hasConcept C2778117937 @default.
• W2016805863 hasConcept C2779758542 @default.
• W2016805863 hasConcept C2781390199 @default.
• W2016805863 hasConcept C2994554258 @default.
• W2016805863 hasConcept C518705261 @default.
• W2016805863 hasConcept C71924100 @default.
• W2016805863 hasConceptScore W2016805863C10162356 @default.
• W2016805863 hasConceptScore W2016805863C142724271 @default.
• W2016805863 hasConceptScore W2016805863C203014093 @default.
• W2016805863 hasConceptScore W2016805863C2776042228 @default.
• W2016805863 hasConceptScore W2016805863C2776914184 @default.
• W2016805863 hasConceptScore W2016805863C2777129736 @default.

• next